Pitt, Jason J.
Riester, Markus http://orcid.org/0000-0002-4759-8332
Zheng, Yonglan http://orcid.org/0000-0001-6597-7072
Yoshimatsu, Toshio F. http://orcid.org/0000-0003-2674-8159
Sanni, Ayodele
Oluwasola, Olayiwola
Veloso, Artur
Labrot, Emma
Wang, Shengfeng
Odetunde, Abayomi
Ademola, Adeyinka
Okedere, Babajide
Mahan, Scott
Leary, Rebecca
Macomber, Maura
Ajani, Mustapha
Johnson, Ryan S.
Fitzgerald, Dominic
Grundstad, A. Jason
Tuteja, Jigyasa H.
Khramtsova, Galina
Zhang, Jing
Sveen, Elisabeth
Hwang, Bryce
Clayton, Wendy
Nkwodimmah, Chibuzor
Famooto, Bisola
Obasi, Esther
Aderoju, Victor
Oludara, Mobolaji
Omodele, Folusho
Akinyele, Odunayo
Adeoye, Adewunmi
Ogundiran, Temidayo
Babalola, Chinedum
MacIsaac, Kenzie
Popoola, Abiodun
Morrissey, Michael P.
Chen, Lin S.
Wang, Jiebiao
Olopade, Christopher O.
Falusi, Adeyinka G.
Winckler, Wendy
Haase, Kerstin http://orcid.org/0000-0002-0944-5618
Van Loo, Peter http://orcid.org/0000-0003-0292-1949
Obafunwa, John
Papoutsakis, Dimitris
Ojengbede, Oladosu
Weber, Barbara
Ibrahim, Nasiru
White, Kevin P.
Huo, Dezheng
Olopade, Olufunmilayo I. http://orcid.org/0000-0002-9936-1599
Barretina, Jordi http://orcid.org/0000-0002-3478-4080
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U01-CA161032)
Article History
Received: 8 October 2017
Accepted: 13 September 2018
First Online: 16 October 2018
Change Date: 14 January 2019
Change Type: Correction
Change Details: The original version of this Article contained an error in the author affiliations. The affiliation of Kevin P. White with Tempus Labs, Inc. Chicago, IL, USA was inadvertently omitted. This has now been corrected in both the PDF and HTML versions of the Article.
Competing interests
: The authors declare the following competing interests: M.R., A.V., E.L., S.M., R.L., M.M., R.S.J., B.H., KM, M.P.M., W.W., D.P., B.W., and J.B. are all employees of Novartis Institutes for BioMedical Research. K.P.W. serves as President at Tempus. O.I.O is an equity stock holder of CancerIQ and Tempus. All other authors declare no competing interest.